MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/jaha.125.044366

Медицинская библиотека · Journal of the American Heart Association · 2026

Cardiovascular Risk Management in Adults With Diagnosed Diabetes in Mexico From 2016 to 2023: A Retrospective Analysis of Nationally Representative Surveys.

Ramírez-García Daniel, Perezalonso-Espinosa Jerónimo, Méndez-Labra Padme Nailea, Fermín-Martínez Carlos A, Díaz-Sánchez Juan Pablo, Paz-Cabrera César Daniel, Vargas-Vázquez Arsenio, López-Teros Miriam Teresa, Flood David, Manne-Ghoeler Jennifer, Antonio-Villa Neftali Eduardo, Danaei Goodarz, Seiglie Jacqueline A, Bello-Chavolla Omar Yaxmehen

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Effective cardiovascular disease (CVD) risk management is essential for optimal diabetes care. Here, we estimated the prevalence and determinants of CVD risk factor control among individuals with diagnosed diabetes in Mexico.

METHODS

We analyzed data from individuals ≥20 years with diagnosed diabetes from 2016 to 2023 Mexican National Health and Nutrition Surveys. We estimated the prevalence of glycemic, blood pressure, noncurrent smoking, low-density lipoprotein cholesterol, and combined CVD risk factor control. We estimated use of blood pressure-lowering, cholesterol-lowering, and glucose-lowering medication and explored determinants of control achievement using logistic regression.

RESULTS

We analyzed data from 2916 participants, representing 43.2 million adults with diagnosed diabetes during 2016 to 2023. In 2023, glycemic control was 29% (95% CI, 21%-38%), blood pressure control 22.9% (95% CI, 14%-31%), and noncurrent smoking 89% (95% CI, 81%-96%). The prevalence of high or very-high CVD risk using Systematic Coronary Risk Evaluation 2-Diabetes increased from 59.8% (95% CI, 52.1%-67.0%) in 2016 to 68.4% (95% CI, 55.6%-78.9%) in 2023, representing ~5.1 million adults. Low-density lipoprotein cholesterol control increased from 2.8% (95% CI, 1.2%-4.4%) in 2016 to 6.6% (95% CI, 1.9%-11.2%) in 2023 and statin use from 5.5% in 2016 to 63% in 2023. Combined risk factor control achievement was low due to suboptimal low-density lipoprotein cholesterol control and was more likely achieved in women, younger individuals, and those with college education or living in states with higher socioeconomic position.

CONCLUSIONS

Despite increasing CVD risk during this period, glycemic and CVD risk factor management for adults with diabetes in Mexico remains suboptimal. Our findings suggest a need for strategies to improve CVD risk management to reduce diabetes-related mortality and complications.

Для цитирования: Ramírez-García Daniel, Perezalonso-Espinosa Jerónimo, Méndez-Labra Padme Nailea, Fermín-Martínez Carlos A, Díaz-Sánchez Juan Pablo, Paz-Cabrera César Daniel, Vargas-Vázquez Arsenio, López-Teros Miriam Teresa, Flood David, Manne-Ghoeler Jennifer, Antonio-Villa Neftali Eduardo, Danaei Goodarz, Seiglie Jacqueline A, Bello-Chavolla Omar Yaxmehen. Cardiovascular Risk Management in Adults With Diagnosed Diabetes in Mexico From 2016 to 2023: A Retrospective Analysis of Nationally Representative Surveys.. Journal of the American Heart Association. 2026. DOI: 10.1161/jaha.125.044366.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.